Zebra Capital Management LLC Castle Biosciences Inc Transaction History

Zebra Capital Management LLC

  • $20 Million
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$58.92 - $97.33 $902,065 - $1.49 Million
-15,310 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$43.6 - $73.05 $52,058 - $87,221
1,194 Added 8.46%
15,310 $1.03 Million
Q3 2020

Nov 16, 2020
BUY
$38.47 - $52.03 $543,042 - $734,455
14,116 New
14,116 $726,000

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $695M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email